Explore more publications!

Malawi ink five-year USD936M health deal with the US to fight HIV/AIDS

(MENAFN) Malawi has signed a five-year, $936 million bilateral health cooperation agreement with the United States to tackle major public health challenges, including HIV/AIDS, malaria, and tuberculosis. The deal, formalized through a Memorandum of Understanding (MoU) under the America First Global Health Strategy, seeks to strengthen Malawi’s national health system while
also “protecting the United States from global infectious disease threats.”

State Department spokesman Tommy Pigot said that, pending congressional approval, the US plans to provide nearly $300 million over the next five years to support Malawi’s efforts against these diseases and other infectious threats. In addition, Malawi will increase its annual health spending by $143.8 million throughout the MoU period.

Madalitso Baloyi, Malawi’s Minister of Health and Sanitation, stated that the agreement will bolster the country’s capacity to fight infectious diseases at a time when US aid cuts have strained the health sector. “Since the US aid cut about a year ago, we have struggled to fund certain initiatives in the health sector. This bilateral agreement, therefore, is going to ease most of our health challenges,” Baloyi explained.

MENAFN19012026000045017281ID1110619330


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions